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The primary treatment for pemphigus vulgaris is
systemic therapy with high-dose corticosteroids and
immunosuppressants. Topical measures such as 
hydrotherapy, topical glucocorticoids and topical
antimicrobial agents also play a role in disease 
management. However, some patients show a poor
response to these conventional therapies. Silver-
containing hydrofiber dressing patches (SHD;
Aquacel-Ag®; ConvaTec, Skillman, NJ, USA) were
previously reported to be safe and effective in the
management of partial-thickness burns and toxic 
epidermal necrolysis [1,2]. Here, we report a case of
pemphigus vulgaris involving 62% of the total body
surface area (TBSA) with an initial poor response to
oral glucocorticoids and topical silver sulfadiazine
(SSD) therapy. This patient showed dramatic wound
healing with reduced patient discomfort after the
application of SHD.
CASE PRESENTATION
A 47-year-old female with no significant past medical
history presented with a 2-month history of oral
ulcers and multiple bullae and erosions on an erythe-
matous base distributed on her head, neck, trunk and
all four limbs. The area of skin affected was extensive,
with 62% of the TBSA involved (Figure 1). A skin
biopsy was performed, and histopathology and direct
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Pemphigus vulgaris is a life-threatening autoimmune bullous dermatosis and its management
represents a major challenge to medical teams. The primary treatments for pemphigus vulgaris
are oral steroids and immunosuppressants, but topical approaches also play a role in disease
management. Here, we report a patient with pemphigus vulgaris involving 62% of the total body
surface area, with initial poor clinical response to systemic steroids and topical silver sulfadiazine
therapy. However, a marked improvement in wound healing and decreased patient discomfort
were observed after application of silver-containing hydrofiber dressings (Aquacel-Ag®).
Therefore, silver-containing hydrofiber dressings may offer an effective adjunct in the treatment
of patients with pemphigus vulgaris with extensive skin involvement. Our encouraging experi-
ence with these dressing patches may be extended to manage other large exudation wounds.
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immunofluorescence led to a diagnosis of pemphi-
gus vulgaris. Therefore, the patient was admitted for
further treatment.
Initially, the patient (body weight, 55 kg) was
treated systemically with oral prednisolone starting
at 40 mg/day and increasing to 100 mg/day over 
2 weeks. There were significant amounts of wound
exudate, and Pseudomonas aeruginosa was cultured
from the wound, so an intravenous antibiotic (cipro-
floxacin 400 mg, twice-daily) was administered. Daily
hydrotherapy was commenced and daily change of
wound dressings was performed with the applica-
tion of an SSD cream to the wounds, which were then
covered with gauze. Despite these measures, no obvi-
ous improvement was noted after 3 weeks in terms of
the affected TBSA and wound condition. In addition,
the patient suffered considerable pain and distress
during the daily hydrotherapy sessions and dressing
changes, necessitating frequent use of intramuscular
pethidine.
Because of the poor wound healing, large amount
of wound exudate, and intractable pain, SHD therapy
was started 3 weeks after admission. SHD was used
to dress all of the patient’s wounds. The wounds were
first cleansed with normal saline under sterile condi-
tions, and SHD was then applied to the wounds. The
SHD was covered with gauze and conforming band-
ages to keep it in place. The dressings were changed
every 3 days, and the wounds were not disturbed
between each dressing change. No other topical agents
were applied, and hydrotherapy and topical SSD
were discontinued.
After starting SHD therapy, a marked improve-
ment in wound healing was noted, and the affected
TBSA steadily decreased from 62% to 5% over 
4 weeks (Figure 2A). No new skin lesions were noted
1 week after starting SHD therapy. Dressing changes
took only 45 minutes every 3 days with SHD, com-
pared with 2 hours every day with hydrotherapy 
and SSD care. The patient also experienced less pain
and discomfort during the dressing changes. Oral
prednisolone was gradually reduced to 40 mg/day
(Figure 3). The patient was discharged 4 weeks after
starting SHD therapy and was able to return to nor-
mal activities. She continued to use SHD to dress her
wounds at home. Two months after starting SHD
therapy, her wounds had completely healed, leaving
only patches of hyperpigmentation (Figure 2B).
DISCUSSION
Pemphigus vulgaris is a serious autoimmune muco-
cutaneous bullous disease with potentially signifi-
cant morbidity and mortality. In addition to the use
of systemic glucocorticoids and immunosuppressive
therapy to control the autoimmune response, the
choice of an appropriate dressing material to pro-
mote wound healing is also an important aspect of
pemphigus vulgaris management.
SHD is made from the hydrocolloid polymer car-
boxymethylcellulose to which silver ions are
attached. The dressing fibers absorb wound exudate
and swell to form a soft cohesive gel that covers the
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Figure 1. (A, B) Multiple large erythematous erosions on the trunk and four limbs on admission.
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wound surface [3]. Because of its ability to absorb
large volumes of exudate (up to 20 times its weight in
fluid), it is suitable for heavily exudating wounds [4].
By retaining fluid in the dressing over the wound,
SHD dehydrates less quickly than other dressings
and promotes a moist healing environment. It also
limits lateral movement of fluid, and therefore avoids
maceration of surrounding skin [5].
SHD contains silver cations (which constitute 1.2%
of the total weight of SHD) bound to the highly
absorbent anionic carboxymethylcellulose fibers. Upon
hydration, these silver ions are slowly and continu-
ously released [6]. Topical silver has broadspectrum
antimicrobial activity that is bactericidal against
many antibiotic-resistant wound pathogens, includ-
ing Staphylococcus aureus and Pseudomonas aeruginosa
[7–9]. Low concentrations of silver ions have been
reported to be therapeutic with minimal toxicity to
mammalian cells [10]. Compared with antibiotics,
microbial resistance to silver is rare [11]. SHD is capa-
ble of delivering a sustained release of silver ions
over at least a 14-day period [8]. In contrast, the silver
ions in topical solutions and creams (such as SSD) are
rapidly inactivated by other ions (such as chloride)
present in body fluids; therefore, multiple daily
applications are required for such approaches [6].
SHD was found to be safe and effective in partial-
thickness burns. Caruso et al showed that the use 
Figure 2. Significant improvements in wound condition and affected total body surface area at (A) 4 weeks and (B) 2 months after
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Figure 3. Changes in affected total body surface area and oral prednisolone dose during the patient’s hospital stay. SHD= silver-
containing hydrofiber dressing.
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of SHD resulted in complete healing in approxi-
mately 77% of patients with second-degree burns,
with an average healing time of 11.6 days [1]. Com-
pared with SSD, SHD was associated with less pain
during dressing changes in the management of par-
tial-thickness burns [12]. In addition, SHD was found
to promote wound healing in a patient with toxic epi-
dermal necrolysis with extensive skin involvement
[2]. Because our patient also suffered from erosions
affecting large areas of skin, SHD was used to dress
her wounds. Four weeks after starting SHD therapy,
a dramatic improvement in wound condition and
affected TBSA was noted in our patient. This is the
first report in the scientific literature showing the ben-
eficial effects of SHD in the management of autoim-
mune bullous diseases.
Compared with traditional topical treatment
modalities, SHD has many advantages. It has good
wound healing properties through its ability to absorb
large amounts of exudate, provide a moist healing
environment, and minimize maceration of the sur-
rounding skin. From our experience, SHD is easy to
apply and remove (due to its strong tensile strength),
and can be lifted from the wound in one piece. There-
fore, SHD reduces patient pain and discomfort, and
is time-saving during dressing changes. SHD has
strong antimicrobial effects, because of its silver con-
tent and its ability to absorb and retain wound exu-
dates [4]. These properties of SHD allowed us to
discontinue hydrotherapy in our patient, which was
associated with significant pain. Because of the large
fluid absorption capacity and sustained release of sil-
ver ions from SHD, fewer dressing changes were
required, thus reducing unwanted patient discomfort
and saving time for healthcare personnel. This is in
contrast with silver sulfadiazine creams, which require
frequent removal and reapplication owing to the
rapid inactivation of silver ions in body fluids and the
development of pseudoeschar [7]. SHD is also cost-
effective by decreasing the length of hospital stay
and producing savings in clinical time.
One of the limitations of this report is that SHD
was used to cover all of the patient’s lesions. Therefore,
it was not possible to compare lesions covered by the
SHD with lesions that were not covered by the SHD.
We are currently performing studies to compare the
efficacy of SHD with other dressing methods in the
management of patients with pemphigus vulgaris. 
In addition, we would like to emphasize that oral
prednisolone played a major role in controlling dis-
ease activity. Therefore, the clinical improvement in
our patient was not due to the action of SHD alone.
In conclusion, the use of topical SHD in combina-
tion with systemic steroids may facilitate wound
healing in some patients with pemphigus vulgaris.
The beneficial effects of SHD may be mediated by 
its ability to provide an optimal wound healing envi-
ronment and its antimicrobial properties. The use 
of SHD as a dressing material also decreases patient
discomfort, and saves manpower, time and cost.
Although we cannot overemphasize the effect of SHD
in pemphigus management, we do believe that SHD
played a significant role in promoting wound healing
in our patient. Our experience with SHD patches was
encouraging, and further studies are needed to eval-
uate the efficacy of these dressing patches in the man-
agement of other bullous disorders and cutaneous
wounds.
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天疱瘡是一種有可能致命的皮膚水疱病，它的治療對醫療團隊是一個很大的挑戰。目
前主要的治療方法是口服類固醇或免疫抑制劑，可是外用藥也扮演重要的角色。我們
在此報告一位天疱瘡的病人，病灶面積已侵犯體表面積百分之六十二，起初對口服類
固醇及外用磺胺銀軟膏治療效果不彰，但是將換藥方式改用含銀親水性纖維敷料之
後，傷口癒合有明顯改善，而且病人的不舒服感也降低。因此，含銀親水性纖維敷料
對於影響病灶範圍較大的天疱瘡病人是一種有效的輔助療法。我們對於這種敷料的成
功經驗，可以應用到其他傷口範圍大而且滲出液較多的疾病。
關鍵詞：天疱瘡，含銀親水性纖維敷料，傷口癒合
(高雄醫誌 2009;25:622–7)
